The paper reports the results of a computational study on compounds capable of inhibiting the prion-like infection mechanism of superoxide dismutase-1 (SOD1) mutants, which are the basis of amyotrophic lateral sclerosis (ALS). Here, SOD1 is linked to amyotrophic lateral sclerosis.